NASDAQ: DCTHDelcath Systems Inc Stock Ownership - Who owns Delcath Systems?
Insider buying vs selling
Have Delcath Systems Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Vojo Vukovic | CHIEF MEDICAL OFFICER | 2025-06-12 | 42,000 | $4.78 | $200.76kBuy |
| Gil Aharon | Director | 2025-05-05 | 400,000 | $10.00 | $4.00MBuy |
| Rosalind Advisors Inc | Director | 2025-05-05 | 400,000 | $10.00 | $4.00MBuy |
| Steven A. J. Salamon | Director | 2025-05-05 | 400,000 | $10.00 | $4.00MBuy |
| Gil Aharon | Director | 2024-12-24 | 250,000 | $10.00 | $2.50MBuy |
| Steven A. J. Salamon | Director | 2024-12-24 | 250,000 | $10.00 | $2.50MBuy |
| Rosalind Advisors Inc | Director | 2024-12-24 | 250,000 | $10.00 | $2.50MBuy |
| Gerard J. Michel | CHIEF EXECUTIVE OFFICER | 2024-10-22 | 16,666 | $6.00 | $100.00kBuy |
DCTH insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when DCTH insiders and whales buy or sell their stock.
DCTH Shareholders
What type of owners hold Delcath Systems Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Rosalind Advisors Inc | 26.27% | 9,190,404 | $104.31M | Insider |
| Steven A. J. Salamon | 20.77% | 7,267,079 | $82.48M | Insider |
| Gil Aharon | 20.48% | 7,164,449 | $81.32M | Insider |
| Rosalind Advisors Inc | 9.43% | 3,300,389 | $37.46M | Institution |
| Blackrock Inc | 4.91% | 1,717,197 | $19.49M | Institution |
| Vanguard Group Inc | 4.60% | 1,610,735 | $18.28M | Institution |
| Deerfield Management Company LP | 2.32% | 812,561 | $9.22M | Institution |
| Citadel Advisors LLC | 2.30% | 803,208 | $9.12M | Institution |
| Geode Capital Management LLC | 2.01% | 703,171 | $7.98M | Institution |
| Vivo Capital LLC | 1.63% | 569,526 | $6.46M | Institution |
DCTH vs Medical Device Stocks
Delcath Systems Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.